188 related articles for article (PubMed ID: 34103321)
1. Active vaccine safety surveillance of seasonal influenza vaccination via a scalable, integrated system in Western Australian pharmacies: a prospective cohort study.
Salter S; Singh G; Nissen L; Trentino K; Murray K; Lee K; Kop B; Peters I; Leeb A
BMJ Open; 2021 Jun; 11(6):e048109. PubMed ID: 34103321
[TBL] [Abstract][Full Text] [Related]
2. Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety.
Glover C; Crawford N; Leeb A; Wood N; Macartney K
Vaccine; 2020 Jun; 38(31):4892-4900. PubMed ID: 32499067
[TBL] [Abstract][Full Text] [Related]
3. Active SMS-based influenza vaccine safety surveillance in Australian children.
Pillsbury A; Quinn H; Cashman P; Leeb A; Macartney K;
Vaccine; 2017 Dec; 35(51):7101-7106. PubMed ID: 29128379
[TBL] [Abstract][Full Text] [Related]
4. Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia.
Pillsbury AJ; Glover C; Jacoby P; Quinn HE; Fathima P; Cashman P; Leeb A; Blyth CC; Gold MS; Snelling T; Macartney KK
BMJ Open; 2018 Oct; 8(10):e023263. PubMed ID: 30341132
[TBL] [Abstract][Full Text] [Related]
5. Annual report: surveillance of adverse events following immunisation in Australia, 2004.
Lawrence GL; Boyd I; McIntyre PB; Isaacs D
Commun Dis Intell Q Rep; 2005; 29(3):248-62. PubMed ID: 16220860
[TBL] [Abstract][Full Text] [Related]
6. Allergic adverse events following 2015 seasonal influenza vaccine, Victoria, Australia.
Clothier HJ; Crawford N; Russell MA; Buttery JP
Euro Surveill; 2017 May; 22(20):. PubMed ID: 28552101
[TBL] [Abstract][Full Text] [Related]
7. Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older.
Pillsbury AJ; Fathima P; Quinn HE; Cashman P; Blyth CC; Leeb A; Macartney KK
JAMA Netw Open; 2020 May; 3(5):e204079. PubMed ID: 32369177
[TBL] [Abstract][Full Text] [Related]
8. Safety of live attenuated herpes zoster vaccine in Australian adults 70-79 years of age: an observational study using active surveillance.
Phillips A; Glover C; Leeb A; Cashman P; Fathima P; Crawford N; Snelling TL; Durrheim D; Macartney K
BMJ Open; 2021 Mar; 11(3):e043880. PubMed ID: 33766842
[TBL] [Abstract][Full Text] [Related]
9. Annual report: Surveillance of adverse events following immunisation in Australia, 2005.
Lawrence G; Boyd I; McIntyre P; Isaacs D
Commun Dis Intell Q Rep; 2006; 30(3):319-33. PubMed ID: 17120485
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and feasibility of SMS m-Health for the detection of adverse events following immunisation (AEFIs) in resource-limited setting-The Zimbabwe stimulated telephone assisted rapid safety surveillance (Zm-STARSS) randomised control trial.
Nyambayo PPM; Gold MS; Mehta UC; Clarke S; Manyevere R; Chirinda L; Zifamba EN; Nyamandi T
Vaccine; 2023 Oct; 41(45):6700-6709. PubMed ID: 37805357
[TBL] [Abstract][Full Text] [Related]
11. Annual report: surveillance of adverse events following immunisation in Australia, 2009.
Mahajan D; Roomiani I; Gold MS; Lawrence GL; McIntyre PB; Menzies RI
Commun Dis Intell Q Rep; 2010 Sep; 34(3):259-76. PubMed ID: 21090181
[TBL] [Abstract][Full Text] [Related]
12. Post-vaccination healthcare attendance rate as a proxy measure for syndromic surveillance of adverse events following immunisation.
Mesfin YM; Cheng AC; Enticott J; Lawrie J; Buttery J
Aust N Z J Public Health; 2021 Apr; 45(2):101-107. PubMed ID: 33617131
[TBL] [Abstract][Full Text] [Related]
13. Real-time safety surveillance of seasonal influenza vaccines in children, Australia, 2015.
Pillsbury A; Cashman P; Leeb A; Regan A; Westphal D; Snelling T; Blyth C; Crawford N; Wood N; Macartney K;
Euro Surveill; 2015; 20(43):. PubMed ID: 26536867
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of adverse events following immunisation: Australia 2002 to 2003.
Lawrence G; Boyd I; McIntyre P; Isaacs D
Commun Dis Intell Q Rep; 2004; 28(3):324-38. PubMed ID: 15574056
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the first pharmacist-administered vaccinations in Western Australia: a mixed-methods study.
Hattingh HL; Sim TF; Parsons R; Czarniak P; Vickery A; Ayadurai S
BMJ Open; 2016 Sep; 6(9):e011948. PubMed ID: 27650763
[TBL] [Abstract][Full Text] [Related]
16. Annual report: surveillance of adverse events following immunisation in Australia, 2007.
Lawrence G; Gold MS; Hill R; Deeks S; Glasswell A; McIntyre PB
Commun Dis Intell Q Rep; 2008 Dec; 32(4):371-87. PubMed ID: 19374268
[TBL] [Abstract][Full Text] [Related]
17. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.
Deng L; Glover C; Dymock M; Pillsbury A; Marsh JA; Quinn HE; Leeb A; Cashman P; Snelling TL; Wood N; Macartney K
Med J Aust; 2022 Aug; 217(4):195-202. PubMed ID: 35781813
[TBL] [Abstract][Full Text] [Related]
18. Active surveillance for influenza vaccine adverse events: the integrated vaccine surveillance system.
Newes-Adeyi G; Greece J; Bozeman S; Walker DK; Lewis F; Gidudu J
Vaccine; 2012 Feb; 30(6):1050-5. PubMed ID: 22200501
[TBL] [Abstract][Full Text] [Related]
19. Seasonal influenza vaccination delivery through community pharmacists in England: evaluation of the London pilot.
Atkins K; van Hoek AJ; Watson C; Baguelin M; Choga L; Patel A; Raj T; Jit M; Griffiths U
BMJ Open; 2016 Feb; 6(2):e009739. PubMed ID: 26883237
[TBL] [Abstract][Full Text] [Related]
20. Using SMS to monitor adverse events following trivalent influenza vaccination in pregnant women.
Regan AK; Blyth CC; Mak DB; Richmond PC; Effler PV
Aust N Z J Obstet Gynaecol; 2014 Dec; 54(6):522-8. PubMed ID: 25306915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
